AI:AM podcast: Gamow Labs uses AI agents to investigate rare genetic diseases
danielmckinn0n · x · 2026-10-06
The latest AI:AM episode features Joel Borgen on AI-assisted fiction and human agency, and Daniel McKinnon on how a family tragedy led him to build Gamow Labs, using AI agents to investigate rare genetic diseases and the limits of model scaffolding (benchmark and clinical figures are his reported findings, not independently validated).
Hosts Nathan Labenz and Prakash Narayanan also review OpenAI's DevDay through two lenses: consumer-facing agent products like Dots and using a ChatGPT subscription inside other apps, versus frontier capabilities outpacing oversight — plus AI welfare, government services, and the case for independent safety audits.
More from AGI Musings
- Miles Brundage: Since o3, AI Can Easily Geolocate Photos — But People Still Post Them — Miles_Brundage · 2026-10-06
- Australian unions and top AI institutes issue joint statement on sovereign AI — TobyWalsh · 2026-10-06
- Mercor pitches $95/hr AI training jobs as economists question the skill-distillation model — TheseFact · 2026-10-06
- Social media use explains just 0.4% of teen well-being variation, researcher argues studies fail policy — asusarla · 2026-10-06
- "Kissing the Ring Won't Save You": Scholars Clash Over AI Doomerism vs. Hype — DavidSKrueger · 2026-10-06
- AI Safety Researcher Slams "It Will Replace You If You Don't Embrace It" AI Marketing — DavidSKrueger · 2026-10-06